HLA-Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus HLA-Matched Unrelated Donor Transplantation for Myelodysplastic Syndrome

被引:0
|
作者
Nakaya, Yosuke [1 ]
Koh, Hideo [2 ]
Konuma, Takaaki [3 ]
Shimomura, Yoshimitsu [4 ,5 ]
Ishiyama, Ken [6 ]
Itonaga, Hidehiro [7 ]
Hino, Masayuki [1 ]
Doki, Noriko [8 ]
Nishida, Tetsuya [9 ]
Ohigashi, Hiroyuki [10 ]
Matsuoka, Ken-ichi [11 ]
Kanda, Yoshinobu [12 ]
Maruyama, Yumiko [13 ]
Sawa, Masashi [14 ]
Eto, Tetsuya [15 ]
Hiramoto, Nobuhiro [4 ]
Fukuda, Takahiro [16 ]
Atsuta, Yoshiko [17 ,18 ]
Nakamae, Hirohisa [1 ]
机构
[1] Osaka Metropolitan Univ, Grad Sch Med, Dept Hematol, Osaka, Japan
[2] Osaka Metropolitan Univ, Grad Sch Med, Dept Prevent Med & Environm Hlth, Osaka, Japan
[3] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan
[4] Kobe City Med Ctr Gen Hosp, Dept Hematol, Kobe, Japan
[5] Osaka Univ, Grad Sch Med, Dept Environm Med & Populat Sci, Suita, Japan
[6] Natl Ctr Global Hlth & Med, Dept Hematol, Tokyo, Japan
[7] Nagasaki Univ Hosp, Transfus & Cell Therapy Unit, Nagasaki, Japan
[8] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan
[9] Nagoya Daiichi Hosp, Japanese Red Cross Aichi Med Ctr, Dept Hematol, Nagoya, Japan
[10] Hokkaido Univ Hosp, Dept Hematol, Sapporo, Japan
[11] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan
[12] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan
[13] Univ Tsukuba Hosp, Dept Hematol, Tsukuba, Japan
[14] Anjo Kosei Hosp, Dept Hematol & Oncol, Anjo, Japan
[15] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan
[16] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[17] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Japan
[18] Aichi Med Univ, Sch Med, Dept Registry Sci Transplant & Cellular Therapy, Nagakute, Japan
来源
TRANSPLANTATION AND CELLULAR THERAPY | 2024年 / 30卷 / 03期
关键词
Myelodysplastic; syndrome; Peripheral blood stem; cell transplantation; Haploidentical donor; Matched unrelated donor; Post-transplantation; cyclophosphamide; BONE-MARROW-TRANSPLANTATION; WORLD-HEALTH-ORGANIZATION; MYELOID NEOPLASMS; ACUTE-LEUKEMIA; TRUMP DATA; IMPACT; CLASSIFICATION; DISPARITY; SURVIVAL; REVISION;
D O I
10.1016/j.jtct.2023.10.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Allogeneic hematopoietic cell transplantation (allo-HCT) is the sole curative therapy for myelodysplastic syndrome (MDS). In the absence of an HLA-matched sibling donor, an HLA-matched unrelated donor (MUD) is considered the leading candidate. However, in recent decades, the alternative donor pool has been extended to HLA-haploidentical donors, especially with the development of graft -versus -host disease (GVHD) prophylaxis using post -transplantation cyclophosphamide (PTCy). Comparative data for haploidentical
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor
    Junichi Sugita
    Takashi Kuroha
    Jun Ishikawa
    Tetsuya Eto
    Kentaro Fukushima
    Isao Yokota
    Koichi Akashi
    Shuichi Taniguchi
    Mine Harada
    Takanori Teshima
    [J]. Bone Marrow Transplantation, 2024, 59 : 344 - 349
  • [32] Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor
    Sugita, Junichi
    Kuroha, Takashi
    Ishikawa, Jun
    Eto, Tetsuya
    Fukushima, Kentaro
    Yokota, Isao
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Teshima, Takanori
    [J]. BONE MARROW TRANSPLANTATION, 2024, 59 (03) : 344 - 349
  • [33] Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation
    Mehta, Rohtesh S.
    Saliba, Rima M.
    Rondon, Gabriela
    Al-Atrash, Gheath
    Bashir, Qaiser
    Hosing, Chitra M.
    Kebriaei, Partow
    Khouri, Issa
    Nieto, Yago
    Oran, Betul
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Ramdial, Jeremy
    Srour, Samer A.
    Champlin, Richard E.
    Rezvani, Katayoun
    Shpall, Elizabeth J.
    Alousi, Amin M.
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 695.e1 - 695.e10
  • [34] T Cell-Replete HLA Haploidentical Donor Transplantation with Post-Transplant Cyclophosphamide Is an Effective Salvage for Patients Relapsing after an HLA-Matched Related or Matched Unrelated Donor Transplantation
    Gorgeis, Jessica
    Zhang, Xu
    Connor, Katelin
    Brown, Stacey
    Solomon, Scott R.
    Morris, Lawrence E.
    Holland, H. Kent
    Bashey, Asad
    Solh, Melhem
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1861 - 1866
  • [35] HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia
    Baron, F.
    Labopin, M.
    Tischer, J.
    Ciceri, F.
    Raiola, A. M.
    Blaise, D.
    Sica, S.
    Vydra, J.
    Fanin, R.
    Diez-Martin, J. L.
    Bulabois, C. E.
    Stolzel, F.
    Busca, A.
    Jindra, P.
    Koc, Y.
    Chevallier, P.
    Forcade, E.
    Rosler, W.
    Passweg, J.
    Kulagin, A.
    Carella, A. M.
    Simand, C.
    Bazarbachi, A.
    Pioltelli, P.
    Nagler, A.
    Mohty, M.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 384 - 385
  • [36] Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas
    Mussetti, Alberto
    Kanate, Abraham S.
    Wang, Tao
    He, Meilun
    Hamadani, Mehdi
    Finel, Herve
    Boumendil, Ariane
    Glass, Bertram
    Castagna, Luca
    Dominietto, Alida
    McGuirk, Joseph
    Blaise, Didier
    Gulbas, Zafer
    Diez-Martin, Jose
    Marsh, Steven G. E.
    Paczesny, Sophie
    Gadalla, Shahinaz M.
    Dreger, Peter
    Zhang, Mei-Jie
    Spellman, Stephen R.
    Lee, Stephanie J.
    Bolon, Yung-Tsi
    Sureda, Anna
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (03): : 184e1 - 184e9
  • [37] HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide
    Sugita, Junichi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (01) : 30 - 38
  • [38] HLA-haploidentical stem cell transplantation using posttransplant cyclophosphamide
    Junichi Sugita
    [J]. International Journal of Hematology, 2019, 110 : 30 - 38
  • [39] The Impact of Reduced Dose of Posttransplant Cyclophosphamide in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation
    Sugita, Junichi
    Ota, Shuichi
    Kamimura, Tomohiko
    Omoto, Eijiro
    Kuroha, Takashi
    Matsuo, Keitaro
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Teshima, Takanori
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [40] Comparison of outcomes of haploidentical donor hematopoietic stem cell transplantation supported by third-party cord blood with HLA-matched unrelated donor transplantation
    Lyu, Hairong
    Lu, Wenyi
    Yao, Jianfeng
    Xiao, Xia
    Li, Qing
    Wang, Jia
    Mu, Juan
    Qi, Yao
    Zhu, Haibo
    Jiang, Yili
    Li, Xin
    Meng, Juanxia
    Yuan, Ting
    He, Xiaoyuan
    Jiang, Erlie
    Han, Mingzhe
    Zhao, Mingfeng
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (04) : 840 - 847